Cannara Biotech Inc. is a Canadian-based cannabis company specializing in the vertically integrated production of premium-grade cannabis and cannabis-derivative products for the Canadian market. It focuses on cultivating, processing, and selling high-quality dried flowers, pre-rolls, oils, and other derivatives, emphasizing craft-quality 'AAAA' products through advanced indoor techniques and rare genetics. Operating state-of-the-art facilities in Quebec spanning over 1,650,000 square feet, the company leverages low-cost electricity and labor to achieve efficient, sustainable output for recreational and medical sectors. Cannara Biotech Inc. serves Quebec and broader Canadian markets via provincial distributors, prioritizing consistency, innovation, and transparency in its brands. Its operations include indoor cannabis cultivation and real estate segments supporting production sites like Farnham and Valleyfield. Founded in 2017 and headquartered in Montréal, Quebec, Cannara Biotech Inc. plays a key role in the competitive Canadian cannabis industry by delivering affordable premium products.